GlassScriptPhysician profile
Latonya Mcmorris
NPI 1942725833
$657.93
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $458 · 2022: $53.38 · 2023: $79.83 · 2024: $66.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $270.18 | 2021-2022 | |
| Neurelis, INC. | $110.30 | 2021-2022 | |
| Abbvie INC. | $66.83 | 2024 | |
| Pfizer INC. | $32.98 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $32.54 | 2021 | |
| Janssen Pharmaceuticals, INC | $24.60 | 2023 | Xarelto |
| Sk Life Science, INC. | $22.54 | 2021 | |
| Glaxosmithkline, LLC. | $22.25 | 2023 | Trelegy Ellipta |
| Teva Pharmaceuticals USA, INC. | $22.21 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $19.22 | 2021 | |
| Eisai INC. | $18.79 | 2021 | |
| Lilly USA, LLC | $15.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Latonya Mcmorris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.